{
    "Allocation": "Randomized",
    "CompleteTime": 21,
    "DesignModel": "Parallel Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "abx464: 50  mg  , ",
                "ArmGroupLabel": "ABX464 50mg",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "50mg",
                        "DrugName": "abx464",
                        "Duration": "",
                        "HowToTake": "",
                        "OtherName": [
                            "Obefazimod"
                        ]
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "drug: abx464"
                    ]
                }
            },
            {
                "ArmGroupDescription": "abx464: 50  mg  , ",
                "ArmGroupLabel": "ABX464 25mg",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "25mg",
                        "DrugName": "abx464",
                        "Duration": "",
                        "HowToTake": "",
                        "OtherName": [
                            "Obefazimod"
                        ]
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "drug: abx464"
                    ]
                }
            },
            {
                "ArmGroupDescription": "placebo: 50  mg  , ",
                "ArmGroupLabel": "Placebo",
                "ArmGroupType": "Placebo Comparator",
                "InterventionDescription": [
                    {
                        "Dosage": "50  mg",
                        "DrugName": "placebo",
                        "Duration": "",
                        "HowToTake": "",
                        "OtherName": []
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "drug: placebo"
                    ]
                }
            }
        ]
    },
    "Enrollment": "612",
    "InterventionName": "Placebo",
    "Masking": "Triple",
    "NCTID": "NCT05507216",
    "Objective": "ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2",
    "OfficialTitle": "A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis",
    "PopulationBox": {
        "Condition": "Ulcerative Colitis",
        "Gender": "All",
        "HealthyCondition": "No",
        "MaxAge": "",
        "MinAge": "16 Years",
        "Participant": "612"
    },
    "PopulationRatio": "",
    "Title": "ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2",
    "WashoutPeriod": "",
    "_id": "NCT05507216",
    "version": "1.7.1"
}